Norepinephrine

Producers shown on SFDA

(Record date:02/09/2021）

Producers shown on EP

Not showing any

Producer:Wuhan Wuyao Pharmaceutical Co., Ltd. is a holding subsidiary invested by Broad (China) Co., Ltd. (formerly Wuhan Pharmaceutical Factory) in 2002. It is a well-known enterprise in the production and operation of specialty drug substances in China. The company passed the acceptance of "secondary enterprise of safety production standardization"; in the same year, it was rated as "high-tech enterprise" in Hubei Province; the annual sales income is 600 million yuan, and the products are exported to more than 40 countries and regions such as Europe and the United States, and the total annual export value $ 50 million.

According to the Opinions of the People's Government of Wuhan City on Accelerating the Relocation and Remediation of Chemical Production Enterprises in the Third Ring Road of the City (Wuzheng [2008] No. 50) and the overall plan, Wuhan Wuyao Pharmaceutical Co., Ltd. was relocated to Yangxin County, Huangshi City, Hubei Province. Chemical Industrial Park of Fuchi Town. The company currently has 820 employees and 500 technical and management personnel with college education or above. With a registered capital of 61 million yuan, the company is a high-tech enterprise engaged in the production and operation of bulk drugs.

Staff size:800-899 persons

Registered capital:RMB 61 million 

Producer:Shanxi Zhendong Taisheng Pharmaceutical Co., Ltd. is a holding subsidiary of Zhendong group.

Zhendong pharmaceutical is a health industry group whose traditional Chinese medicine has passed gap, medicine, health food has passed GMP and food has passed SC certification.

There are 11 main dosage forms, covering eight drug series, 548 product specifications, and the planting area of traditional Chinese medicine has reached more than 200000 mu. It has an international scientific research center established in cooperation with Europe, America, Australia and other countries. It is a national postdoctoral scientific research workstation.

Registered capital:RMB 395 million

For supply and market information, please feel free to contact Mr. Paul, paulzhang@yinuopharmchem.com, WhatsApp: +86 18402846978